Published in Cancer Weekly, October 28th, 2003
The invention, described under U.S. Patent No. 6,623,721, describes the synthesis and application of a new family of molecules known as high affinity bifunctional chelators containing hydroxamic acid residues. Chelators are organic molecules with the property to bind metals with high affinity. These unique and proprietary chelators can be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.